Study Evaluating Effexor XR in Elderly Patients With Major Depression.

Phase III Study of Effexor XR for the Treatment of Elderly Patients With Depression

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00225485

Enrollment

100

Registered

2005-09-23

Start date

2003-12-31

Completion date

Unknown

Last updated

2007-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Depression

Brief summary

Phase III study evaluating Effexor XR in elderly patients with major depression.

Interventions

DRUGEffexor XR

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients diagnosed with major depression based on DSM-IV-TR * Patients having minimal total score of 18 on the HAM-D17 and minimal score of 2 on the item of depressed mood of HAM-D at baseline

Exclusion criteria

* Patients with schizophrenia or any other psychotic disorder * Patients with history or presence of bipolar disorder

Design outcomes

Primary

Measure	Time frame
Response rate of HAM-D17 (Hamilton Rating Scale for Depression) at the final-on-therapy	—

Secondary

Measure	Time frame
Difference of total score of HAM-D17 between baseline and final-on-therapy	—
Remission rate of HAM-D17 at the final-on-therapy	—

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026